These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8128450)

  • 1. Factor VIII and factor IX Sub-Committee. Recommendations for the assay of high-purity factor VIII concentrates.
    Barrowcliffe TW
    Thromb Haemost; 1993 Nov; 70(5):876-7. PubMed ID: 8128450
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor VIII test in reference preparations: compensation for different dilutions.
    König H; Rosenkranz S; Nawrot R; Hunfeld A; Seitz R
    Pharmeur Sci Notes; 2005 Aug; 2005(1):11-3. PubMed ID: 17687888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation and chromogenic assays of factor VIII activity: general aspects, standardization, and recommendations.
    Barrowcliffe TW; Raut S; Sands D; Hubbard AR
    Semin Thromb Hemost; 2002 Jun; 28(3):247-56. PubMed ID: 12098084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues with the assay of factor VIII activity in plasma and factor VIII concentrates.
    Lundblad RL; Kingdon HS; Mann KG; White GC
    Thromb Haemost; 2000 Dec; 84(6):942-8. PubMed ID: 11154139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of clotting factor VIII activity in mammals using the one-stage clotting and the chromogenic methods].
    Lutze G; Lutze G; Kutschmann K; Schröpel M
    Berl Munch Tierarztl Wochenschr; 2002; 115(7-8):297-302. PubMed ID: 12174728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromogenic assay of human coagulation factor VIII: statistical comparison of 2 working dilution procedures.
    Alonso C; Gonzalez A; Frutos G
    Pharmeur Sci Notes; 2005 Aug; 2005(1):31-8. PubMed ID: 17687892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A collaborative study to establish a Korean Standard for factor VIII:C concentrate.
    Kang HN; Kim SN; Lee SH; Hong SH
    Thromb Res; 2004; 113(3-4):261-7. PubMed ID: 15140591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.
    Kirschbaum N; Wood L; Lachenbruch P; Weinstein M; Daas A; Rautmann G; Spieser JM; Buchheit KH
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):31-64. PubMed ID: 12448031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay.
    Ramasamy I; Farrugia A; Tran E; Anastasius V; Charnock A
    Biologicals; 1998 Jun; 26(2):155-66. PubMed ID: 9811523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates.
    Rosén S
    Thromb Haemost; 2001 Oct; 86(4):1132-3. PubMed ID: 11686346
    [No Abstract]   [Full Text] [Related]  

  • 12. A modified chromogenic assay for the measurement of very low levels of factor VIII activity (FVIII:C).
    Yatuv R; Dayan I; Baru M
    Haemophilia; 2006 May; 12(3):253-7. PubMed ID: 16643210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standards for assay of von Willebrand factor concentrates: a collaborative study.
    Fricke WA; Lamb MA; Rastogi SC
    Thromb Haemost; 1993 Aug; 70(2):351-6. PubMed ID: 8236147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
    Kasper CK; Aronson DL; Davignon G; Foster P; Hillman-Wiseman C; Lusher JM; Manco-Johnson M; Meade JB; Montgomery RR; Rickles FR
    Thromb Haemost; 1995 Sep; 74(3):987-9. PubMed ID: 8571334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR; Rigsby P; Barrowcliffe TW
    Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factor VIII preparations of varying purity-examination of physico-chemical parameters (author's transl)].
    Vukovich T; Koller E; Doleschel W; Mayr WR
    Wien Klin Wochenschr; 1980; 92(11):385-91. PubMed ID: 6775418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo recovery of factor VIII following transfusion: a survey of recent data and publications to assess the influence of standards used for potency assignment. On behalf of the Subcommittee on Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
    Prowse CV
    Thromb Haemost; 1995 Oct; 74(4):1191-6. PubMed ID: 8560434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chromogenic assay allows reliable measurement of factor VIII levels in the presence of strong lupus anticoagulants.
    de Maistre E; Wahl D; Perret-Guillaume C; Regnault V; Clarac S; Briquel ME; Andre E; Lecompte T
    Thromb Haemost; 1998 Jan; 79(1):237-8. PubMed ID: 9459356
    [No Abstract]   [Full Text] [Related]  

  • 19. International reference standards in coagulation.
    Raut S; Hubbard AR
    Biologicals; 2010 Jul; 38(4):423-9. PubMed ID: 20338786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A collaborative study to establish the 6th International Standard for factor VIII concentrate.
    Raut S; Heath AB; Barrowcliffe TW
    Thromb Haemost; 2001 Jun; 85(6):1071-8. PubMed ID: 11434687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.